Psychiatry Alerts This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory.

Linezolid Toxic With Prozac, Other SSRIs, FDA Warns
(MedPage Today) -- The FDA has issued an updated statement on the potential for serious central nervous system toxicity when patients taking serotonergic psychiatric drugs are treated with the antibacterial agent linezolid (Zyvox). (Source: MedPage Today Product Alert)
Source: MedPage Today Product Alert - October 21, 2011 Category: Drugs & Pharmacology Source Type: alerts

Diabetes and Anti-Cholesterol Agents Top Outpatient Drug Expenditures
ROCKVILLE, Md. (MedPage Today) -- Americans spent more in 2006 on drugs for diabetes and other metabolic disorders than for any other class of medications, although psychiatric drugs cost more per prescription, said researchers here. (Source: MedPage Today Product Alert)
Source: MedPage Today Product Alert - February 6, 2009 Category: Drugs & Pharmacology Source Type: alerts

FDA Orders ADHD Drug Advisories for Patients
ROCKVILLE, Md. -- The FDA has ordered all drugs approved for attention deficit hyperactivity disorder to carry guides to inform patients about the potential for cardiovascular risks and adverse psychiatric symptoms. (Source: MedPage Today Product Alert)
Source: MedPage Today Product Alert - February 22, 2007 Category: Drugs & Pharmacology Source Type: alerts

APA: New Drugs and Brain Stimulation Offer Hope for Treatment-Resistant Depression
TORONTO -- Vagus nerve stimulation and a newer monoamine oxadase inhibitor available in a transdermal patch are new options for management of treatment-resistant depression, according to speakers at symposia held in conjunction with the American Psychiatric Association meeting here. (Source: MedPage Today Product Alert)
Source: MedPage Today Product Alert - June 27, 2006 Category: Drugs & Pharmacology Source Type: alerts

APA: Diagnostic And Treatment Challenges In Bipolar Disorder Remain
TORONTO -- Major ongoing challenges in bipolar disorder include accurate diagnosis, appropriate treatment selection, and patient adherence, said speakers at a symposium held in conjunction with the American Psychiatric Association meeting. (Source: MedPage Today Product Alert)
Source: MedPage Today Product Alert - June 24, 2006 Category: Drugs & Pharmacology Source Type: alerts

APA: Body Dysmorphic Disorder Linked to Suicidality
TORONTO -- Patients with body dysmorphic disorder are at a high risk for suicidal thoughts and actions, according to research reported at the American Psychiatric Association meeting here. (Source: MedPage Today Product Alert)
Source: MedPage Today Product Alert - June 24, 2006 Category: Drugs & Pharmacology Source Type: alerts

APA: Stay Out Of Interrogations, Psychiatrists Urged
TORONTO -- The American Psychiatric Association called today on its members to steer clear of direct or indirect participation in interrogations of prisoners, whether they are held by military or civilian authorities. (Source: MedPage Today Product Alert)
Source: MedPage Today Product Alert - May 22, 2006 Category: Drugs & Pharmacology Source Type: alerts